CMS’ oncology model launched in 2016 as a five-year, voluntary bundled payment program that incentivizes practices to provide better care at a lower cost by achieving episode-based cost performance and quality measures. While all practices in the program are enrolled in a one-sided risk arrangement — under which a practice will share any savings from hitting those metrics — that will change in July.
At that time, CMS plans to require practices that haven’t achieved a performance-based payment in their first four performance periods to enter a two-sided risk program or exit the model. Under a two-sided risk program, practices share in any savings, but also any losses. The two-sided risk model can either be the original program or a new iteration proposed by CMS — but about half of participants who enter the new program could still face recoupments.
“Many practices that could be required to switch to two-sided risk will likely face recoupment payments to CMS in future performance periods,” Biruk Bekele, consultant at Avalere, said in the brief. “The decision to drop out of the OCM or switch to the new track will be decided on a practice-by-practice basis and will depend on many factors.”
More articles on healthcare finance:
Trump is drafting order to force healthcare cost disclosures, Wall Street Journal reports
Tennessee hospital halts admissions as closure looms
Henry Ford Health System’s net income surges 500% in Q1
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.